GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect®
                                 basiliximab is an approved drug (FDA (1998), EMA (1998)) Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
                                    
                                   View more information in the IUPHAR Pharmacology Education Project: basiliximab | 
| Classification  | |
| Compound class | Antibody | 
| Approved drug? | Yes. EU EMA (1998) | US FDA (1998) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 7578 | basiliximab | 
| Synonyms  | 
| CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect® | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 148 | 
| Other databases | |
| GtoPdb PubChem SID | 178103461 | 
| PubChem SID | 178103461 | 
| Search PubMed clinical trials | basiliximab | 
| Search PubMed titles | basiliximab | 
| Search PubMed titles/abstracts | basiliximab | 
| Wikipedia | Basiliximab |